a public good project by the
Synthesis
Company
of California

© 2026

Yat Sun Or | doi.page

0 works0 citations0 h-index

Yat Sun Or

Enanta Pharmaceuticals (United States)(US)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Pneumonia and Respiratory Infections, Carbohydrate Chemistry and Synthesis

Most-Cited Works

→ Pentaprismane(1981)151 cited
→ In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450(2014)117 cited
→ Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens(2001)112 cited
→ Design, Synthesis, and Antimicrobial Activity of 6-O-Substituted Ketolides Active against Resistant Respiratory Tract Pathogens(2000)104 cited
→ The synthesis of pentaprismane(1986)90 cited
→ In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir(2017)88 cited

→ Synthesis and Antimicrobial Activity of 4H-4-Oxoquinolizine Derivatives: Consequences of Structural Modification at the C-8 Position(1999)

61 cited

→ Studies on the synthesis of the antitumor agent CC-1065. Synthesis of the unprotected cyclopropapyrroloindole A portion using the 3,3'-bipyrrole strategy(1987)60 cited

→ Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist(2018)60 cited

→ Structure-function studies in a series of carboxyl-terminal octapeptide analogs of anaphylatoxin C5a(1992)49 cited